Nephroprotection diabetes mellitus type 2: lessons from the ADVANCE trial

Nedogoda, S.V.

Kardiologiia 51(12): 57-59

2011


ISSN/ISBN: 0022-9040
PMID: 22304318
Document Number: 650145
Based on the results of the ADVANCE study, the article considers the issues of medication nephroprotection in patients with type 2 diabetes mellitus, including patients with uncontrolled arterial hypertension. Potentials for use of fixed combination of perindopril + indapmide, which provides therapeutic effect at all stages of renal continuum, are discussed. It is established that improved control of blood pressure by combination of perindopril + indapmide leads to a significant decrease in mortality in DM 2 patients.

Document emailed within 1 workday
Secure & encrypted payments